F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum adiponectin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood adiponectin amount |
male |
211 days
| 11 |
3.02 |
ng/ml |
0.15 |
0.5 |
enzyme linked immunosorbent assay |
0.0 |
|
0 |
|
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
67481 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
blood glucose level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood glucose amount |
male |
211 days
| 11 |
82.5 |
mg/dl |
3.5 |
11.61 |
oral glucose tolerance test |
0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
12792 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight to body weight ratio |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
mesenteric fat pad mass |
male |
218 days
| 11 |
2.06 |
% |
0.09 |
0.3 |
post excision weight measurement |
0.0 |
|
0 |
|
|
67469 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight to body weight ratio |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
retroperitoneal fat pad mass |
male |
218 days
| 11 |
2.47 |
% |
0.09 |
0.3 |
post excision weight measurement |
0.0 |
|
0 |
|
|
67473 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum insulin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood insulin amount |
male |
211 days
| 11 |
0.0 |
mg/dl |
0.0 |
0.0 |
oral glucose tolerance test |
0.0 |
oral glucose |
0 |
min |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
67477 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 11 |
6.28 |
ng/ml |
0.51 |
1.69 |
enzyme linked immunosorbent assay |
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
67485 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum free fatty acids level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood free fatty acid amount |
male |
218 days
| 11 |
0.66 |
mmol/l |
0.05 |
0.16 |
serum free fatty acid analysis |
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
67497 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
body weight |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
body mass |
male |
211 days
| 11 |
425.3 |
g |
5.3 |
17.58 |
body weighing method |
0.0 |
oral glucose |
0 |
min |
|
12797 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
mesenteric fat pad mass |
male |
218 days
| 11 |
8.8 |
g |
0.4 |
1.33 |
post excision weight measurement |
|
|
0 |
|
|
12794 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
epididymal fat pad mass |
male |
218 days
| 11 |
10.6 |
g |
0.3 |
0.99 |
post excision weight measurement |
|
|
0 |
|
|
12796 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
retroperitoneal fat pad mass |
male |
218 days
| 11 |
10.5 |
g |
0.4 |
1.33 |
post excision weight measurement |
|
|
0 |
|
|
12795 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood cholesterol amount |
male |
218 days
| 11 |
72.7 |
mg/dl |
2.13 |
7.06 |
serum total cholesterol measurement test |
0.0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
12793 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 11 |
113.5 |
mg/dl |
4.81 |
15.95 |
serum triglyceride analysis |
0 |
|
0 |
|
Wako Pure Chemicals, Tokyo, Japan |
13194 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight to body weight ratio |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
epididymal fat pad mass |
male |
218 days
| 11 |
2.49 |
% |
0.06 |
0.2 |
post excision weight measurement |
0.0 |
|
0 |
|
|
67493 |
311 |